These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
505 related articles for article (PubMed ID: 28454829)
1. Design and rationale of the COMPARE-ACUTE trial: Fractional flow reserve-guided primary multivessel percutaneous coronary intervention to improve guideline indexed actual standard of care for treatment of ST-elevation myocardial infarction in patients with multivessel coronary disease. Smits PC; Assaf A; Richardt G; Omerovic E; Abdel-Wahab M; Neumann FJ Am Heart J; 2017 Apr; 186():21-28. PubMed ID: 28454829 [TBL] [Abstract][Full Text] [Related]
2. Rationale and design of the Flow Evaluation to Guide Revascularization in Multivessel ST-Elevation Myocardial Infarction (FLOWER-MI) trial. Puymirat E; Simon T; de Bruyne B; Montalescot G; Steg G; Cayla G; Durand-Zaleski I; Blanchard D; Danchin N; Chatellier G; Am Heart J; 2020 Apr; 222():1-7. PubMed ID: 32000067 [TBL] [Abstract][Full Text] [Related]
3. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization). Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE; Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623 [TBL] [Abstract][Full Text] [Related]
4. Compared Outcomes of ST-Segment-Elevation Myocardial Infarction Patients With Multivessel Disease Treated With Primary Percutaneous Coronary Intervention and Preserved Fractional Flow Reserve of Nonculprit Lesions Treated Conservatively and of Those With Low Fractional Flow Reserve Managed Invasively: Insights From the FLOWER-MI Trial. Denormandie P; Simon T; Cayla G; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; le Breton H; Valy Y; Schiele F; Cuisset T; Vanzetto G; Levesque S; Goube P; Nallet O; Angoulvant D; Roubille F; Charles Nelson A; Chatellier G; Danchin N; Puymirat E Circ Cardiovasc Interv; 2021 Nov; 14(11):e011314. PubMed ID: 34420366 [TBL] [Abstract][Full Text] [Related]
5. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy. Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010 [TBL] [Abstract][Full Text] [Related]
6. FFR- Versus Angiography-Guided Revascularization for Nonculprit Stenosis in STEMI and Multivessel Disease: A Network Meta-Analysis. Elbadawi A; Dang AT; Hamed M; Eid M; Prakash Hiriyur Prakash M; Saleh M; Gad M; Mamas MA; Rahman F; Elgendy IY JACC Cardiovasc Interv; 2022 Mar; 15(6):656-666. PubMed ID: 35331458 [TBL] [Abstract][Full Text] [Related]
7. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Engstrøm T; Kelbæk H; Helqvist S; Høfsten DE; Kløvgaard L; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Lancet; 2015 Aug; 386(9994):665-71. PubMed ID: 26347918 [TBL] [Abstract][Full Text] [Related]
8. Multivessel PCI Guided by FFR or Angiography for Myocardial Infarction. Puymirat E; Cayla G; Simon T; Steg PG; Montalescot G; Durand-Zaleski I; le Bras A; Gallet R; Khalife K; Morelle JF; Motreff P; Lemesle G; Dillinger JG; Lhermusier T; Silvain J; Roule V; Labèque JN; Rangé G; Ducrocq G; Cottin Y; Blanchard D; Charles Nelson A; De Bruyne B; Chatellier G; Danchin N; N Engl J Med; 2021 Jul; 385(4):297-308. PubMed ID: 33999545 [TBL] [Abstract][Full Text] [Related]
9. FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial Infarction. Böhm F; Mogensen B; Engstrøm T; Stankovic G; Srdanovic I; Lønborg J; Zwackman S; Hamid M; Kellerth T; Lauermann J; Kajander OA; Andersson J; Linder R; Angerås O; Renlund H; Ērglis A; Menon M; Schultz C; Laine M; Held C; Rück A; Östlund O; James S; N Engl J Med; 2024 Apr; 390(16):1481-1492. PubMed ID: 38587995 [TBL] [Abstract][Full Text] [Related]
10. Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) 3 Trial: a comparison of fractional flow reserve-guided percutaneous coronary intervention and coronary artery bypass graft surgery in patients with multivessel coronary artery disease. Zimmermann FM; De Bruyne B; Pijls NH; Desai M; Oldroyd KG; Park SJ; Reardon MJ; Wendler O; Woo J; Yeung AC; Fearon WF Am Heart J; 2015 Oct; 170(4):619-626.e2. PubMed ID: 26386784 [TBL] [Abstract][Full Text] [Related]
12. Meta-Analysis Comparing Fractional Flow Reserve and Angiography-Guided Complete Revascularization of Nonculprit Artery for ST-Elevation Myocardial Infarction. Omar A; Senguttuvan NB; Ueyama H; Kuno T; Beerkens F; Rahim M; Elmariah H; Takagi H; Abdulkader RS; Yallanki HP; Pelliccia F; Mylavarapu DP; Claessen B; Pasceri V; Dangas G Am J Cardiol; 2022 Nov; 183():8-15. PubMed ID: 36115726 [TBL] [Abstract][Full Text] [Related]
13. Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis. Bainey KR; Engstrøm T; Smits PC; Gershlick AH; James SK; Storey RF; Wood DA; Mehran R; Cairns JA; Mehta SR JAMA Cardiol; 2020 Aug; 5(8):881-888. PubMed ID: 32432651 [TBL] [Abstract][Full Text] [Related]
14. Coronary angiography- or fractional flow reserve-guided complete revascularization in multivessel disease STEMI: A Bayesian hierarchical network meta-analysis. Archilletti F; Ricci F; Pelliccia F; Dangas G; Giuliani L; Radico F; Perfetti M; Rossi S; Gallina S; Maddestra N; Khanji MY; Zimarino M Int J Cardiol; 2023 Jan; 370():122-128. PubMed ID: 36328114 [TBL] [Abstract][Full Text] [Related]
15. Cost-Effectiveness of Fractional Flow Reserve-Guided Treatment for Acute Myocardial Infarction and Multivessel Disease: A Prespecified Analysis of the FRAME-AMI Randomized Clinical Trial. Hong D; Lee SH; Lee J; Lee H; Shin D; Kim HK; Park KH; Choo EH; Kim CJ; Kim MC; Hong YJ; Jeong MH; Ahn SG; Doh JH; Lee SY; Don Park S; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Guallar E; Cho J; Hahn JY; Kang D; Lee JM; JAMA Netw Open; 2024 Jan; 7(1):e2352427. PubMed ID: 38270954 [TBL] [Abstract][Full Text] [Related]
16. Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial. Lee JM; Kim HK; Park KH; Choo EH; Kim CJ; Lee SH; Kim MC; Hong YJ; Ahn SG; Doh JH; Lee SY; Park SD; Lee HJ; Kang MG; Koh JS; Cho YK; Nam CW; Koo BK; Lee BK; Yun KH; Hong D; Joh HS; Choi KH; Park TK; Yang JH; Song YB; Choi SH; Gwon HC; Hahn JY; Eur Heart J; 2023 Feb; 44(6):473-484. PubMed ID: 36540034 [TBL] [Abstract][Full Text] [Related]
17. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. Pijls NH; Fearon WF; Tonino PA; Siebert U; Ikeno F; Bornschein B; van't Veer M; Klauss V; Manoharan G; Engstrøm T; Oldroyd KG; Ver Lee PN; MacCarthy PA; De Bruyne B; J Am Coll Cardiol; 2010 Jul; 56(3):177-84. PubMed ID: 20537493 [TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial. Kornowski R; Mehran R; Dangas G; Nikolsky E; Assali A; Claessen BE; Gersh BJ; Wong SC; Witzenbichler B; Guagliumi G; Dudek D; Fahy M; Lansky AJ; Stone GW; J Am Coll Cardiol; 2011 Aug; 58(7):704-11. PubMed ID: 21816305 [TBL] [Abstract][Full Text] [Related]
19. Percutaneous coronary intervention for nonculprit vessels in cardiogenic shock complicating ST-segment elevation acute myocardial infarction. Yang JH; Hahn JY; Song PS; Song YB; Choi SH; Choi JH; Lee SH; Jeong MH; Choi DJ; Kim YJ; Gwon HC Crit Care Med; 2014 Jan; 42(1):17-25. PubMed ID: 24105454 [TBL] [Abstract][Full Text] [Related]
20. Timing of fractional flow reserve-guided complete revascularization in patients with ST-segment elevation myocardial infarction with multivessel disease: Rationale and design of the OPTION-STEMI trial. Kim MC; Ahn JH; Hyun DY; Lim Y; Lee SH; Oh S; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Cho JH; Lee SR; Kang DO; Hwang JY; Youn YJ; Jeong YH; Park Y; Kim DB; Choo EH; Kim CJ; Kim W; Rhew JY; Lee JH; Yoo SY; Ahn Y; Am Heart J; 2024 Jul; 273():35-43. PubMed ID: 38641031 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]